Dopamine inactivation efficacy related to functional DAT1 and COMT variants influences motor response evaluation

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Bender, Stephan ^a,b,c   Rellum, Thomas ^d   Freitag, Christine ^b   Resch, Franz ^c   Rietschel, Marcella ^d   Treutlein, Jens ^d   Jennen Steinmetz, Christine ^d   Brandeis, Daniel ^d,e   Banaschewski, Tobias ^d   Laucht, Manfred ^d,f  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f UNIVERSITY OF POTSDAM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE TRANSPORTER; DOPAMINE; PRIMER DNA; SLC6A3 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADOLESCENT; ARTICLE; COMT GENE; CONTINGENT NEGATIVE VARIATION; DAT1 GENE; DNA POLYMORPHISM; ELECTROENCEPHALOGRAM; EVOKED MUSCLE RESPONSE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HORMONE INHIBITION; HUMAN; HUMAN EXPERIMENT; INTRON; MOTOR CORTEX; NORMAL HUMAN; PARIETAL LOBE; TANDEM REPEAT; TASK PERFORMANCE; ELECTROENCEPHALOGRAPHY; GENETIC POLYMORPHISM; GENETICS; GERMANY; INTELLIGENCE TEST; LONGITUDINAL STUDY; METABOLISM; MISSENSE MUTATION; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOMOTOR PERFORMANCE; STATISTICAL MODEL; TIME; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; CATECHOL O-METHYLTRANSFERASE; CONTINGENT NEGATIVE VARIATION; DNA PRIMERS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ELECTROENCEPHALOGRAPHY; GENOTYPE; GERMANY; HAPLOTYPES; HUMANS; INTELLIGENCE TESTS; LINEAR MODELS; LONGITUDINAL STUDIES; MINISATELLITE REPEATS; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE; TIME FACTORS;

EID: 84861361994     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037814     Document Type: Article

References (63)

1. Rockstroh B, Elbert T, Canavan A, Lutzenberger W, Birbaumer N, (1989) Slow cortical potentials and behavior Baltimore Urban & Schwarzenberg.
2. Bender S, Resch F, Weisbrod M, Oelkers-Ax R, (2004) Specific task anticipation versus unspecific orienting reaction during early contingent negative variation. Clin Neurophysiol 115: 1836-1845.
3. Gaillard AW, (1977) The late CNV wave: preparation versus expectancy. Psychophysiology 14: 563-568.
4. Rohrbaugh JW, Syndulko K, Sanquist TF, Lindsley DB, (1980) Synthesis of the contingent negative variation brain potential from noncontingent stimulus and motor elements. Science 208: 1165-1168.
5. Gomez CM, Marco J, Grau C, (2003) Preparatory visuo-motor cortical network of the contingent negative variation estimated by current density. Neuroimage 20: 216-224.
6. Bender S, Weisbrod M, Bornfleth H, Resch F, Oelkers-Ax R, (2005) How do children prepare to react? Imaging maturation of motor preparation and stimulus anticipation by late contingent negative variation. Neuroimage 27: 737-752.
7. Klein C, Andresen B, Berg P, Kruger H, Rockstroh B, (1998) Topography of CNV and PINV in schizotypal personality. Psychophysiology 35: 272-282.
8. Klein C, Rockstroh B, Cohen R, Berg P, Dressel M, (1996) The impact of performance uncertainty on the postimperative negative variation. Psychophysiology 33: 426-433.
9. Bender S, Becker D, Oelkers-Ax R, Weisbrod M, (2006) Cortical motor areas are activated early in a characteristic sequence during post-movement processing. Neuroimage 32: 333-351.
10. Seamans JK, Yang CR, (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74: 1-58.
11. Coull JT, (1998) Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Prog Neurobiol 55: 343-361.
12. Kahkonen S, Ahveninen J, Pekkonen E, Kaakkola S, Huttunen J, et al. (2002) Dopamine modulates involuntary attention shifting and reorienting: an electromagnetic study. Clin Neurophysiol 113: 1894-1902.
13. Linssen AM, Vuurman EF, Sambeth A, Nave S, Spooren W, et al. (2011) Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate. Psychopharmacology (Berl).
14. Verleger R, Wascher E, Arolt V, Daase C, Strohm A, et al. (1999) Slow EEG potentials (contingent negative variation and post-imperative negative variation) in schizophrenia: their association to the present state and to Parkinsonian medication effects. Clin Neurophysiol 110: 1175-1192.
15. Karoum F, Chrapusta SJ, Egan MF, (1994) 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 63: 972-979.
16. Sesack SR, Hawrylak VA, Guido MA, Levey AI, (1998) Cellular and subcellular localization of the dopamine transporter in rat cortex. Adv Pharmacol 42: 171-174.
17. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, et al. (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243-250.
18. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, et al. (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34: 4202-4210.
19. VanNess SH, Owens MJ, Kilts CD, (2005) The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 6: 55.
20. Shumay E, Chen J, Fowler JS, Volkow ND, (2011) Genotype and ancestry modulate brain's DAT availability in healthy humans. PLoS One 6: e22754.
21. Brookes KJ, Neale BM, Sugden K, Khan N, Asherson P, et al. (2007) Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue. Am J Med Genet B Neuropsychiatr Genet 144B: 1070-1078.
22. Laucht M, Skowronek MH, Becker K, Schmidt MH, Esser G, et al. (2007) Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Arch Gen Psychiatry 64: 585-590.
23. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, et al. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100: 6186-6191.
24. Bertolino A, Blasi G, Latorre V, Rubino V, Rampino A, et al. (2006) Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in human brain. J Neurosci 26: 3918-3922.
25. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, et al. (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98: 6917-6922.
26. Fuster JM, (2000) Executive frontal functions. Exp Brain Res 133: 66-70.
27. Laucht M, Esser G, Schmidt MH, (1997) Developmental outcome of infants born with biological and psychosocial risks. J Child Psychol Psychiatry 38: 843-853.
28. Cattell RB, (1960) Culture Fair Intelligence Test, Scale 2 (Handbook), 3rd edition Champaign, IL Institute for Personality and Ability Testing.
29. Weiß RH, (1987) Grundintelligenztest CFT 20 Göttingen Hogrefe.
30. Kiphardt EJ, Schilling F, (1974) Körperkoordinationstest für Kinder (KTK) Weinheim Beltz.
31. Oldfield RC, (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9: 97-113.
32. van Leeuwen TH, Steinhausen HC, Overtoom CC, Pascual-Marqui RD, van't Klooster B, et al. (1998) The continuous performance test revisited with neuroelectric mapping: impaired orienting in children with attention deficits. Behav Brain Res 94: 97-110.
33. Banaschewski T, Brandeis D, Heinrich H, Albrecht B, Brunner E, et al. (2003) Association of ADHD and conduct disorder-brain electrical evidence for the existence of a distinct subtype. J Child Psychol Psychiatry 44: 356-376.
34. Brandeis D, Banaschewski T, Baving L, Georgiewa P, Blanz B, et al. (2002) Multicenter P300 brain mapping of impaired attention to cues in hyperkinetic children. J Am Acad Child Adolesc Psychiatry 41: 990-998.
35. Bender S, Weisbrod M, Resch F, Oelkers-Ax R, (2007) Stereotyped topography of different elevated contingent negative variation components in children with migraine without aura points towards a subcortical dysfunction. Pain 127: 221-233.
36. Bender S, Weisbrod M, Just U, Pfuller U, Parzer P, et al. (2002) Lack of age-dependent development of the contingent negative variation (CNV) in migraine children? Cephalalgia 22: 132-136.
37. Bender S, Behringer S, Freitag CM, Resch F, Weisbrod M, (2010) Transmodal comparison of auditory, motor, and visual post-processing with and without intentional short-term memory maintenance. Clin Neurophysiol 121: 2044-2064.
38. Bender S, Oelkers-Ax R, Resch F, Weisbrod M, (2004) Motor processing after movement execution as revealed by evoked and induced activity. Brain Res Cogn Brain Res 21: 49-58.
39. Sano A, Kondoh K, Kakimoto Y, Kondo I, (1993) A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 91: 405-406.
40. Vandenbergh DJ, Rodriguez LA, Hivert E, Schiller JH, Villareal G, et al. (2000) Long forms of the dopamine receptor (DRD4) gene VNTR are more prevalent in substance abusers: no interaction with functional alleles of the catechol-o-methyltransferase (COMT) gene. Am J Med Genet 96: 678-683.
41. Yacubian J, Sommer T, Schroeder K, Glascher J, Kalisch R, et al. (2007) Gene-gene interaction associated with neural reward sensitivity. Proc Natl Acad Sci U S A 104: 8125-8130.
42. Prata DP, Mechelli A, Fu CH, Picchioni M, Toulopoulou T, et al. (2009) Epistasis between the DAT 3′ UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc Natl Acad Sci U S A 106: 13600-13605.
43. Bender S, Resch F, Klein C, Renner TJ, Fallgatter A, et al. (in revision) Influence of Stimulant Medication and Response Speed on Lateralization of Movement-Related Potentials in Attention-Deficit/Hyperactivity Disorder. PLoS One.
44. Haggard P, (2008) Human volition: towards a neuroscience of will. Nat Rev Neurosci 9: 934-946.
45. Hallett M, (1994) Movement-related cortical potentials. Electromyogr Clin Neurophysiol 34: 5-13.
46. Bender S, Basseler K, Sebastian I, Resch F, Kammer T, et al. (2005) Electroencephalographic response to transcranial magnetic stimulation in children: Evidence for giant inhibitory potentials. Ann Neurol 58: 58-67.
47. Bruckmann S, Hauk D, Roessner V, Resch F, Freitag C, et al. (in press) Cortical inhibition in attention deficit hyperactivity disorder: new insights from the electroencephalographic response to transcranial magnetic stimulation. Brain.
48. Wickens JR, Reynolds JN, Hyland BI, (2003) Neural mechanisms of reward-related motor learning. Curr Opin Neurobiol 13: 685-690.
49. Masaki H, Wild-Wall N, Sangals J, Sommer W, (2004) The functional locus of the lateralized readiness potential. Psychophysiology 41: 220-230.
50. Ulrich R, Leuthold H, Sommer W, (1998) Motor programming of response force and movement direction. Psychophysiology 35: 721-728.
51. Sommer W, Leuthold H, Ulrich R, (1994) The lateralized readiness potential preceding brief isometric force pulses of different peak force and rate of force production. Psychophysiology 31: 503-512.
52. Bilder RM, Volavka J, Lachman HM, Grace AA, (2004) The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29: 1943-1961.
53. Karoum F, Chrapusta SJ, Brinjak R, Hitri A, Wyatt RJ, (1994) Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. Br J Pharmacol 113: 1391-1399.
54. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, et al. (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 95: 9991-9996.
55. Grace AA, (1995) The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depend 37: 111-129.
56. de Frias CM, Marklund P, Eriksson E, Larsson A, Oman L, et al. (2010) Influence of COMT Gene Polymorphism on fMRI-assessed Sustained and Transient Activity during a Working Memory Task. J Cogn Neurosci 22: 1614-1622.
57. Marklund P, Larsson A, Elgh E, Linder J, Riklund KA, et al. (2009) Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory. Brain 132: 336-346.
58. Meyer-Lindenberg A, Kohn PD, Kolachana B, Kippenhan S, McInerney-Leo A, et al. (2005) Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 8: 594-596.
59. Schultz W, (2007) Behavioral dopamine signals. Trends Neurosci 30: 203-210.
60. Hahn T, Heinzel S, Dresler T, Plichta MM, Renner TJ, et al. (2011) Association between reward-related activation in the ventral striatum and trait reward sensitivity is moderated by dopamine transporter genotype. Hum Brain Mapp 32: 1557-1565.
61. Dreher JC, Kohn P, Kolachana B, Weinberger DR, Berman KF, (2009) Variation in dopamine genes influences responsivity of the human reward system. Proc Natl Acad Sci U S A 106: 617-622.
62. Franke B, Hoogman M, Arias Vasquez A, Heister JG, Savelkoul PJ, et al. (2008) Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD. Am J Med Genet B Neuropsychiatr Genet 147B: 1576-1579.
63. Franke B, Vasquez AA, Johansson S, Hoogman M, Romanos J, et al. (2010) Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacology 35: 656-664.